PFKFB3 and breast carcinoma: Interestingly, La Belle Flynn and collaborators determined a key role for the glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (Pfkfb3) in driving the balance between dormancy and awake in breast cancer cells.